NovaBay Pharmaceuticals Inc (NBY)

0.3042
+0.0015(+0.50%)
After Hours
0.2911
-0.0131(-4.3064%)
- Real-time Data
  • Volume:
    630,829
  • Bid/Ask:
    0.2911/0.3000
  • Day's Range:
    0.2805 - 0.3148

NBY Overview

Prev. Close
0.3027
Day's Range
0.2805-0.3148
Revenue
7.67M
Open
0.29
52 wk Range
0.2805-1.79
EPS
-0.17
Volume
630,829
Market Cap
13.48M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
906,205
P/E Ratio
-
Beta
3.44
1-Year Change
-70.03%
Shares Outstanding
44,943,364
Next Earnings Date
Mar 24, 2022
What is your sentiment on NovaBay Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

NovaBay Pharmaceuticals Inc Company Profile

Employees
24

NovaBay Pharmaceuticals, Inc. is a medical device company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is a solution of hypochlorous acid that acts as an antimicrobial preservative in solution and has been shown to neutralize bacterial toxins in laboratory tests. It develops additional products containing its hypochlorous acid, including NeutroPhase and PhaseOne for the wound care market. The Company's dermatology product includes CelleRx Clinical Reset, which is a facial spray that disrupts the layer of bacteria that settles and grows on the face. Its wound care business includes the business of NeutroPhase and PhaseOne product, which are used for the cleansing and irrigation of intraoperative pocket lavage, stasis ulcers, leg ulcers, diabetic foot ulcers, minor burns, superficial abrasions, wounds and moistening absorbent wound dressings.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellStrong SellStrong Sell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell
  • time to buy
    0
    • Earnings report today.
      0
      • Bought at 0,95
        0
        • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
          0
          • They seem to have good earnings coming
            0
            • itll be amazing
              0
            • today there earnings how you think it's going to be
              0
            • I wish I knew... These days, nothing seems to have any logic nor sense... Just a war between some groups of people...
              0
          • Garbage
            2
            • Target 1.90
              0
              • UP! UP! UP!|
                0
                • https://www.businesswire.com/news/home/20201214005255/en/NovaBay-Pharmaceuticals-Now-Included-in-EPA-N-Listing-of-Products-That ****SARS-CoV-2
                  0
                  • 27%
                    0
                    • It will hit 1.5 again
                      0
                      • When your guess?
                        0
                    • Will the stock rise above 1.4
                      0
                      • Novabay has signed an agreement for online selling with Walmart
                        0
                        • where is the news link, please share
                          0
                        • Syed Hussain  https://www.businesswire.com/news/home/20200818005205/en/NovaBay-Expands-Avenova%E2%80%99s-Online-Distribution
                          0
                      • Why its going up pre market? Whats the news?
                        0
                        • Does anyone see this stock bouncing back, just drops and drops like a brick ! Damage control (sell) or hold ?
                          0
                          • Will stock move up next week
                            2
                            • Do we think stock goes up today or next week? The earnings seemed really positive.
                              1
                              • Hope so...
                                0
                            • Why is this stock going down after eanings were really positive?
                              0
                              • Earnings day tomorrow!
                                0
                                • What do you expect. And whers do you see this stock going?
                                  0
                                • Majed Fadel I expect it to rise more pre earnings date. Note how it has been going up since 29/07. Majed this is not a long term stock in my opinion. Just grab some to make some money quick.
                                  0
                              • Do you think this is a good stock to hold? And for how long?
                                0
                                • Wait for earnings! Should see $2.00 to $2.75 a share, possibly more!
                                  0
                              • Buy and hold...this is going up!!
                                0
                                • What is your price target / forecast next 3-6 months ?
                                  0
                                • where do you buy this stock?
                                  0
                                • Sandeep Karwa 1.32 premarket price...not bad
                                  0
                              • Big news today with Covid **** goong up and up.
                                0
                                • The compnay will announce very strong Q2 results and will extend tue recent gains. Price will hit USD2.65 towards year end
                                  0
                                  • 89 cents good entry. solid company. resistance at 1.15. needs to break through that to run in the 1.25 range
                                    0
                                    • Cyclacel Pharmaceuticals Inc (CYCC) is better
                                      3
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.